Foster Dykema Cabot & CO Inc Embecta Corp. Transaction History
Foster Dykema Cabot & CO Inc
- $827 Million
- Q3 2023
A detailed history of Foster Dykema Cabot & CO Inc transactions in Embecta Corp. stock. As of the latest transaction made, Foster Dykema Cabot & CO Inc holds 59 shares of EMBC stock, worth $834. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59
Previous 59
-0.0%
Holding current value
$834
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EMBC
# of Institutions
403Shares Held
52.5MCall Options Held
215KPut Options Held
83.3K-
Black Rock Inc. New York, NY9.19MShares$130 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.29MShares$103 Million0.0% of portfolio
-
River Road Asset Management, LLC3.48MShares$49.2 Million0.69% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.44MShares$48.7 Million0.02% of portfolio
-
American Century Companies Inc Kansas City, MO3.16MShares$44.7 Million0.02% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $818M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...